Derrick Li serves as Aardvark's Chief Business Officer and is a biotechnology executive with more than 20 years of global experience in biopharmaceutical business development, investment banking and corporate strategy. He previously served as Chief Strategy Officer at ODC Life Sciences and as Head of Strategy and Investor Relations at Cellular Biomedicine Group (now AbelZeta), and held investment banking roles including Managing Director in the Healthcare Investment Group at Robert W. Baird. Mr. Li earned a dual bachelor's degree in accountancy and finance from Villanova University.